Veerhealth Care Limited - 511523 - Results-Financial Results For March 31, 2019
Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Statement showing the Audited Financial Results for the quarter and year ended March 31, 2019. 2. Auditors Report on the Audited Financial Results for the quarter and year ended March 31, 2019. 3. Declaration in respect of Audit Report with Unmodified Opinion. Veerhealth Care Ltd - 511523 - Outcome of Board Meeting
Dear Sir, This is to inform you that the Board of Directors of the Company at its meeting held today, has inter alia, approved the Audited Annual Accounts for the financial year ended March 31, 2019. The Board Meeting commenced at 5.00 p.m. and concluded at 6.00 p.m. Veerhealth Care Limited - 511523 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report22/05/2019 3 Name of the Certifying Firm NIDHI SHAH & ASSOCIATES 4 Name of the Certifying Individual NIDHI SHAH 5Membership TypeACS 6 Membership Number 45720 7 CP No. 16854 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO Veerhealth Care Ltd - 511523 - Closure of Trading Window
Dear Sir, This is to inform that Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and Circular issued by BSE Limited, we wish to inform that the trading window for dealing in the securities of the Company has remain closed from the end of quarter ended 31st March, 2019 till 48 hours after the declaration of financial results. Veerhealth Care Ltd - 511523 - Board Meeting Intimation for This Is To Inform That The Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday, May 28, 2019 At 5.00 P.M. At The Registered Office Of The Company At 629-A Gazdar House, 1St Floor, J.S.S. Marg, Near Kalbadevi Post Office, Mumbai - 400002.
Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve 1. Financial Results for the year ended 31st March, 2019 and the Audited Balance Sheet as at 31st March, 2019, Profit & Loss Account for the year ended on that date together with the reports of the Auditors thereon. 2. Re-appointment of Mr. Bhavin Shah as Managing Director of the Company subject to the approval of the shareholders of the Company. 3. Re-appointment of Ms. Shruti Shah as Executive Director of the Company subject to the approval of the shareholders of the Company. Veerhealth Care Ltd - 511523 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayVeerhealth Care Limited 2CININE882C01035 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0 4Highest Credit Rating during the previous FY - 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: RONY SHAH Designation: COMPANY SECRETARY EmailId: cs@veerhealthcare.net Name of the Chief Financial Officer: AKASH SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: akash@veerhealthcare.net Date: 26/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Veerhealth Care Ltd - 511523 - Certificate Under Regulation 74 (5) Of The SEBI (Depositories And Participants) Regulations, 2018 For The Quarter Ended 31St March, 2019.
Dear Sir, Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended 31st March, 2019. Veerhealth Care Ltd - 511523 - Compliances-Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2019
Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the half year ended March 31, 2019. Veerhealth Care Ltd - 511523 - Compliances-Compliance Certificate For The Period Ended 31St March, 2019
Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the half year ended March 31, 2019 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015.